These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 34278816

  • 1. Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
    Okazaki-Hada M, Maruoka A, Yamamoto M, Ito M, Hirokawa M, Nishikawa M, Akamizu T, Miyauchi A, Toyoda N.
    Thyroid; 2021 Oct; 31(10):1592-1596. PubMed ID: 34278816
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
    Yoshimura Noh J, Momotani N, Fukada S, Ito K, Miyauchi A, Amino N.
    Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
    [Abstract] [Full Text] [Related]

  • 5. A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.
    Zimmermann-Belsing T, Christensen L, Hansen HS, Kirkegaard J, Blichert-Toft M, Feldt-Rasmussen U.
    Thyroid; 2000 Mar; 10(3):275-8. PubMed ID: 10779143
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K, Mozai T.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [Abstract] [Full Text] [Related]

  • 8. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
    Izumi Y, Hidaka Y, Tada H, Takano T, Kashiwai T, Tatsumi KI, Ichihara K, Amino N.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
    [Abstract] [Full Text] [Related]

  • 9. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
    Carlé A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB, Laurberg P.
    Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M, Kawasaki M, Danno H, Kohsaka K, Nakamura T, Hisakado M, Yoshioka W, Kasahara T, Kudo T, Nishihara E, Fukata S, Nishikawa M, Nakamura H, Miyauchi A.
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [Abstract] [Full Text] [Related]

  • 12. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.
    Molnár I, Szentmiklósi JA, Somogyiné-Vári É.
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432
    [Abstract] [Full Text] [Related]

  • 13. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M, Perra E, Melis A, Cianchetti ME, Piga M, Serra A, Pinna G, Mariotti S.
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review.
    Alagöl F, Tanakol R, Boztepe H, Kapran Y, Terzioglu T, Dizdaroglu F.
    Thyroid; 1999 Oct; 9(10):1029-32. PubMed ID: 10560959
    [Abstract] [Full Text] [Related]

  • 17. Positive correlation between type 1 and 2 iodothyronine deiodinases activities in human goiters.
    Pereira VS, Marassi MP, Rosenthal D, Vaisman M, Corrêa da Costa VM.
    Endocrine; 2012 Jun; 41(3):532-8. PubMed ID: 22207295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?
    Gul K, Ozdemir D, Dirikoc A, Oguz A, Tuzun D, Baser H, Ersoy R, Cakir B.
    Endocrine; 2010 Apr; 37(2):253-60. PubMed ID: 20960260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.